SCHEMBL1999197

SCHEMBL1999197

N#Cc1cc2c(c(CN)c1-c1ccccc1Cl)NCCN2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.51
KDM4E B2RXH2 4/20 0.35
POLB P06746 3/20 0.35
PIM1 P11309 2/20 0.35
GAA P10253 2/20 0.35
GLA P06280 1/20 0.35
ATM Q13315 1/20 0.35
LRRK2 Q5S007 1/20 0.34
AR P10275 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33
HIF1A Q16665 2/20 0.33
STAT6 P42226 1/20 0.33
GALR3 O60755 1/20 0.32
DPP8 Q6V1X1 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
STK10 O94804 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995182 0.78 DPP4 (0.52) DPP4ATMMAPTKMT2ADPP8
SCHEMBL14369438 0.74 DPP4 (0.47) DPP4POLBMAPTKMT2ADPP8
SCHEMBL3135076 0.68 DPP4 (1.00) DPP4DPP8
SCHEMBL1992724 0.63 DPP4 (0.46) DPP4
SCHEMBL21484251 0.62 TAAR1 (0.47) DPP4KDM4EGAAARALDH1A1
SCHEMBL2002773 0.61 DPP4 (0.43) DPP4DPP8
SCHEMBL2001399 0.61 DPP4 (0.42) DPP4KDM4EGAAALDH1A1MAPT
SCHEMBL5164493 0.59 DPP4 (0.39) DPP4DPP8
SCHEMBL17266575 0.59 LRRK2 (0.49) DPP4KDM4EPOLBGAALRRK2
SCHEMBL1995242 0.59 DPP4 (0.44) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960384-B2 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US claimed
US-20070249611-A1 DIPEPTIDYL PEPTIDASE INHIBITORS TAKEDA SAN DIEGO, INC. 2007-10-25 US claimed
US-7960384-B2 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-7960384-B2 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20070249611-A1 DIPEPTIDYL PEPTIDASE INHIBITORS TAKEDA SAN DIEGO, INC. 2007-10-25 US disclosed
WO-2007112347-A1 DIPEPTIDYL PEPTIDASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249611-A1 DIPEPTIDYL PEPTIDASE INHIBITORS DPP3, DPP4, DPP7 DPP4 2/4885KDM4E 1903/4885POLB 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.